|

Ocrelizumab (US) Clinical Trials

1 actively recruiting trial across 1 location

▼ -1 trial since June 2026

Also known as: Ocrevus

Top Sponsors

  • Northwestern University1

Indications

Chicago, Illinois1 trial

People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists

Northwestern Memorial Hospital

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.